Delivery Order SPE2DB22D3004-SPE2DB24FPG18
- Not listed
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The contract, valued at $20,772.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The $5,688.05 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through February 9, 2024 and was awarded on February 8, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $18,704.53 firm-fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month injection kits. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
- This federal contract award from the Defense Logistics Agency (DLA) is for the pharmaceutical product Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $14,916.05 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 28, 2025. This award is not associated with a set-aside...
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA), a defense agency. The $32,112.38 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, enabling the efficient procurement of a...
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The contract, valued at $4,222.32, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that supplies a wide range of medical products to various federal agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $11,187.05 and is a firm fixed price arrangement. The award was made by the Defense Logistics Agency (DLA), a defense agency, and the period of performance extends to June 5, 2025. The contract is not set aside and represents an open competition award....
- This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, for a total ceiling value of $4,702.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024....
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $18,177.39, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 1, 2022, with a completion date of September 2, 2022. The contract is a delivery order with a firm fixed-price pricing type. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $2,326.08 and an ultimate completion date of October 24, 2023. The award was made on a firm-fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPG18Delivery Order
This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month injection kits to the Defense Logistics Agency (DLA). The contract has a ceiling value of $16,222.78 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This particular delivery order is one of many issued under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 2/8/24 |